<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02576704</url>
  </required_header>
  <id_info>
    <org_study_id>2015-30</org_study_id>
    <nct_id>NCT02576704</nct_id>
  </id_info>
  <brief_title>Prognostic Value of Myocardial Perfusion Heterogeneity in Normal SPECT Studies</brief_title>
  <acronym>PROMETHE</acronym>
  <official_title>Prognostic Value of Myocardial Perfusion Heterogeneity in Normal Dual Isotope High Speed Myocardial Perfusion Imaging With a Semi Conductor Gamma Camera.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Grenoble</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Grenoble</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Myocardial perfusion imaging is an efficient tool to assess the risk of major cardiac events
      for patients with known or suspected coronary artery disease. If the test is normal, or if
      the abnormalities of perfusion represent less than 10% of the left ventricle myocardium, the
      patient is considered at low risk and should be managed with optimal medical treatment only.

      Recently, new gamma cameras using semi-conductor detectors have been developed. Their
      diagnostic performances have been demonstrated and confronted with various anatomical and
      functional reference techniques, such as coronary angiography and FFR. The prognostic value
      of a normal SPECT MPI has not been specifically assessed yet.

      Coronary microvascular dysfunction (CMVD) has been demonstrated to be an early marker of
      coronary artery disease (CAD). Preliminary data suggest that myocardial perfusion
      heterogeneity (a potential surrogate marker of endothelial dysfunction) can be assessed on
      conventional MP-SPECT, but its additive and independent prognostic value over the presence of
      myocardial ischemia remain unknown.

      Accordingly, the purpose of this study is :

        -  To assess the prognostic value of a normal myocardial perfusion stress imaging using a
           semiconductor gamma camera with a dual isotope high speed protocol,

        -  To evaluate the prognostic value of myocardial perfusion heterogeneity assessed by a new
           automatized image processing method, in normal SPECT MPIs.

      The main hypothesis is that the presence of myocardial perfusion heterogeneity is predictive
      of cardiovascular events in patients referred to the Nuclear Cardiology Department for
      routine evaluation of known or suspected CAD.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      SPECT imaging protocol and analysis Stress tests and SPECTs are performed according to the
      routine protocols in use in our center. Briefly, at peak stress, patients were injected with
      thallium-201. Five to 10 minutes after stress, a 5-minutes supine acquisition was performed
      followed by a 5-minutes prone acquisition. Subsequently, technetium-99m-sestamibi was
      injected, and 2 minutes later a single 5-minutes rest acquisition was performed. During
      stress acquisition, patients were imaged in supine and prone positions with their arms
      positioned over their head. The rest acquisition was only acquired in supine position. The
      gated SPECT studies were performed at each acquisition. Injected activity (IA) was adjusted
      for patient weight. For weights of &lt;80 kg/ 80-100 kg/&gt;100 kg, thallium-201 IAs were 74/92/111
      MBq and technetium-99m-sestamibi IAs were 300/370/450 MBq, respectively. A uniform imaging
      pre-treatment for the reconstruction of raw myocardial perfusion imaging data was applied,
      and images were reconstructed and reoriented to obtain transaxial sections of the left
      ventricle according to the three standard cardiac planes.

      In this study, we use a new mathematic technique from entropy analysis to provide precise,
      objective, automated quantification of perfusion heterogeneity at stress with camera SPECT.
      This method may be a non-invasive imaging to assess coronary microvascular dysfunction.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Composite primary outcome</measure>
    <time_frame>3 years</time_frame>
    <description>number of cardiac death or nonfatal Myocardial Infarction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>first composite secondary outcome</measure>
    <time_frame>3 years</time_frame>
    <description>number of cardiac death or nonfatal Myocardial Infarction or stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>secondary composite secondary outcome</measure>
    <time_frame>3 years</time_frame>
    <description>number of cardiac death or nonfatal Myocardial Infarction or stroke or number of participants with myocardial revascularization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>third composite secondary outcome</measure>
    <time_frame>3 years</time_frame>
    <description>number of all death or nonfatal Myocardial Infarction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fourth composite secondary outcome</measure>
    <time_frame>3 years</time_frame>
    <description>number of all death or nonfatal Myocardial Infarction or stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fifth composite secondary outcome</measure>
    <time_frame>3 years</time_frame>
    <description>number of all death or nonfatal Myocardial Infarction or stroke or number of participants with myocardial revascularization</description>
  </secondary_outcome>
  <enrollment type="Actual">1119</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Coronary Atherosclerosis</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>semi conductor gamma camera</intervention_name>
    <description>we use a new mathematic technique from entropy analysis to provide precise, objective, automated quantification of perfusion heterogeneity at stress with camera SPECT. This method may be a non-invasive imaging to assess coronary microvascular dysfunction.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Study cohort Patient referred to the Nuclear Cardiology Laboratory of the University
        Hospital of Grenoble for myocardial perfusion imaging for diagnosis or prognosis evaluation
        of suspected or know coronary artery disease, whose myocardial stress imaging was normal or
        with Summed stress score (SSS) &lt; or = 4.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Clinical indication for myocardial perfusion imaging

        Exclusion Criteria:

          -  Pregnancy

          -  Breastfeeding women

          -  Myocardial perfusion abnormalities with SSS &gt; 4
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Chu Grenoble</name>
      <address>
        <city>Grenoble</city>
        <state>Isere</state>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Verma S, Buchanan MR, Anderson TJ. Endothelial function testing as a biomarker of vascular disease. Circulation. 2003 Oct 28;108(17):2054-9. Review.</citation>
    <PMID>14581384</PMID>
  </reference>
  <reference>
    <citation>Schindler TH, Nitzsche EU, Schelbert HR, Olschewski M, Sayre J, Mix M, Brink I, Zhang XL, Kreissl M, Magosaki N, Just H, Solzbach U. Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events. J Am Coll Cardiol. 2005 May 3;45(9):1505-12.</citation>
    <PMID>15862426</PMID>
  </reference>
  <reference>
    <citation>Johnson NP, Gould KL. Clinical evaluation of a new concept: resting myocardial perfusion heterogeneity quantified by markovian analysis of PET identifies coronary microvascular dysfunction and early atherosclerosis in 1,034 subjects. J Nucl Med. 2005 Sep;46(9):1427-37.</citation>
    <PMID>16157524</PMID>
  </reference>
  <reference>
    <citation>Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003 Jun 17;107(23):2900-7. Epub 2003 May 27.</citation>
    <PMID>12771008</PMID>
  </reference>
  <reference>
    <citation>Barone-Rochette G, Leclere M, Calizzano A, Vautrin E, CÃ©line GC, Broisat A, Ghezzi C, Baguet JP, Machecourt J, Vanzetto G, Fagret D. Stress thallium-201/rest technetium-99m sequential dual-isotope high-speed myocardial perfusion imaging validation versus invasive coronary angiography. J Nucl Cardiol. 2015 Jun;22(3):513-22. doi: 10.1007/s12350-014-0016-0. Epub 2014 Nov 8.</citation>
    <PMID>25381092</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 13, 2015</study_first_submitted>
  <study_first_submitted_qc>October 13, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 15, 2015</study_first_posted>
  <last_update_submitted>January 2, 2017</last_update_submitted>
  <last_update_submitted_qc>January 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Grenoble</investigator_affiliation>
    <investigator_full_name>Barone-Rochette Gilles</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

